| LINE ITEM (USD / %) | FY 2025
FILED 2026-04-30 | FY 2024
FILED 2025-04-30 | FY 2023
FILED 2024-04-30 |
|---|---|---|---|
| Revenue (Total Sales) | $523.8M | $474.7M | $535.8M |
| YoY Revenue Growth % | +10.4% | -11.4% | — |
| Gross Profit | $141.1M | $127.2M | — |
| Gross Margin % | 26.9% | 26.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $29.2M | $23.9M | $47.1M |
| Operating Margin % | 5.6% | 5.0% | 8.8% |
| Net Income (GAAP) | $18.5M | $13.4M | $41.4M |
| EBITDA (Normalized) | $48.2M | $41.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $114.2M | -$7.2M | $106.7M |
| Capital Expenditures (CapEx) | $23.7M | $21.6M | — |
| Free Cash Flow (FCF) | $90.4M | -$28.8M | $106.7M |
| FCF Margin % | 17.3% | -6.1% | 19.9% |
| Return on Invested Capital (ROIC %) | 6.7% | 5.5% | — |
| Cash & Short-Term Equivalents | $18.4M | $26.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $363.4M | $366.9M | — |